Cryo-EM has emerged as a powerful tool for enabling rapid advances in drug discovery. The scale, simplicity, and economics of AWS promises to transform cryo-EM workflows even further.

However, processing and analyzing large cryo-EM datasets in AWS requires the right architecture and the right data platform.

Join this chat with Baris Guler, HPC Practice Manager at Clovertex to learn:

  • How cryo-EM is impacting drug discovery and the main challenges that exist
  • Why traditional storage approaches aren’t meeting the demands of cryo-EM applications like CryoSPARC
  • How they leverage WEKA with AWS to enable faster drug discovery workflows
  • What benchmarks they have seen and recommendations you can use

If you cannot attend but are interested in this topic, please register to receive an on-demand replay of the webinar. 

Join the Chat


  • Baris Guler

    HPC Practice Manager


  • Phil Curran

    Cloud Strategist